DLC1 Interaction with  -Catenin Stabilizes Adherens Junctions and Enhances DLC1 Antioncogenic Activity

DLC1 Interaction with S100A10 Mediates Inhibition of In Vitro Cell Invasion and Tumorigenicity of Lung Cancer Cells through a RhoGAP-Independent Mechanism

(2011) X. Yang et al.   CANCER RESEARCH

Copy number alterations in prostate tumors and disease aggressiveness

(2011) Iona Cheng et al.   GENES CHROMOSOMES & CANCER

Silencing of DLC1 Upregulates PAI-1 Expression and Reduces Migration in Normal Prostate Cells

(2011) Y.-P. Shih et al.   MOLECULAR CANCER RESEARCH

DLC1 Negatively Regulates Angiogenesis in a Paracrine Fashion

(2010) Y.-P. Shih et al.   CANCER RESEARCH

Expression of the E-cadherin-catenin complex in patients with pancreatic ductal adenocarcinoma.

(2010) Anna Pryczynicz et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.

(2010) Jolanta Czyzewska et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Akt Phosphorylation of Deleted in Liver Cancer 1 Abrogates Its Suppression of Liver Cancer Tumorigenesis and Metastasis

(2010) Frankie Chi Fat Ko et al.   GASTROENTEROLOGY

Genome remodelling in a basal-like breast cancer metastasis and xenograft

(2010) Li Ding et al.   NATURE

Modulation of the Tumor Suppressor Protein α-Catenin by Ischemic Microenvironment

(2009) Claire L. Plumb et al.   AMERICAN JOURNAL OF PATHOLOGY

Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility

(2009) T. Y. Kim et al.   CANCER AND METASTASIS REVIEWS

The cytoskeleton and cancer

(2009) Alan Hall   CANCER AND METASTASIS REVIEWS

Real-time Study of E-Cadherin and Membrane Dynamics in Living Animals: Implications for Disease Modeling and Drug Development

(2009) A. Serrels et al.   CANCER RESEARCH

The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration

(2009) D. Zhong et al.   JOURNAL OF CELL SCIENCE

p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities

(2009) X-Y Yang et al.   ONCOGENE

Rearrangements of the Actin Cytoskeleton and E-Cadherin–Based Adherens Junctions Caused by Neoplasic Transformation Change Cell–Cell Interactions

(2009) Dmitry V. Ayollo et al.   PLoS One

Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy

(2008) M Guan et al.   CANCER GENE THERAPY

Microenvironmental regulation of E-cadherin-mediated adherens junctions

(2008) Klaudia Giehl   Frontiers in Bioscience-Landmark

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma

(2008) W. Xue et al.   GENES & DEVELOPMENT

DLC1: a significant GAP in the cancer genome

(2008) A. Lahoz et al.   GENES & DEVELOPMENT

Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration

(2008) Tai Young Kim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling

(2008) R.-P. Scholz et al.   JOURNAL OF CELL SCIENCE

DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway

(2008) V Ullmannova-Benson et al.   LEUKEMIA

A two-tiered mechanism for stabilization and immobilization of E-cadherin

(2008) Matthieu Cavey et al.   NATURE

Deleted in liver cancer-1 (DLC-1): A tumor suppressor not just for liver

(2007) Yi-Chun Liao et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms

(2007) Kevin D. Healy et al.   MOLECULAR CARCINOGENESIS